Actively Recruiting
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
Led by Massachusetts General Hospital · Updated on 2026-03-05
100
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
CONDITIONS
Official Title
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years of age or older
- Planned endoscopic procedure
- American Society of Anesthesiologists (ASA) Physical Status I to III
You will not qualify if you...
- Planned tracheal intubation
- Procedure length anticipated to exceed 45 minutes
- Previously participated in the trial
- Pregnant or breastfeeding
- Allergy or hypersensitivity to one of the study medications
- Blind, deaf, or unable to communicate in English
- Co-enrollment in other interventional studies that might interfere with this study participation or data collection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02214
Actively Recruiting
Research Team
O
Oluwaseun Johnson-Akeju, MD
CONTACT
A
Ariel Mueller, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here